More importantly, as insiders tie their personal wealth to these companies, they provide a useful confidence signal for investors. Let’s examine some of the more interesting companies in the present macro landscape.) shareholders, Opaleye Management Inc. raised its stake by $434,000 at the stock price range between $6.77 and $7.22 per share. In September, Opaleye made two insider purchases worth 107,500 shares at a price range between $4.65 and $4.75 per share.
The common thread across these drugs is the treatment of rare to ultra-rare and hereditary diseases. Most recently on October 3rd, Eton initiated the acquisition of Increlex from French Ipsen Pharmaceuticals, which should be completed by the end of 2024. In October’s fiscal Q1 2025 earnings, AngioDynamics reported $67.5 million net sales, divided between Med Tech and Med Device divisions. The former category tracked 8.7% growth while the latter declined 3.6% YoY.
Nasdaq’s average price target for ANGO has a substantial upside potential at $13 per share based on 6 analyst inputs.Standing out from the biotech crowd in this insider buys roundup, tile Shop Holdings sells natural stone and man-made tiles from ceramic to luxury vinyl. Insiders from Pleasant Lake Partners and Pleasant Lake Onshore Feeder Fund, via Fund 1 Investments manager, bought $78k worth of Tile Shop Holdings Inc (NASDAQ:TTSH stock is currently priced at $6.
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »
مصدر: Investingcom - 🏆 450. / 53 اقرأ أكثر »